NCT01110694View on ClinicalTrials.gov

Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Idiopathic Pulmonary FibrosisIdiopathic Non-specific Interstitial Pneumonitis
Trial Locations (1)

SW3 6NP

Royal Brompton Hospital, London

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

University College, London

OTHER

collaborator

University of Nottingham

OTHER

lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER

NCT01110694 - Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study | Biotech Hunter | Biotech Hunter